Cart is empty A multinational research team of clinicians and scientists from South Korea and Singapore has published positive findings from a phase 2 clinical trial for a new combination therapy for an aggressive, Asian-prevalent blood cancer, extranodal NK/T-cell lymphoma.
Leave A Comment